Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

LY4257496

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 6, 2026 · PHASE 1 TRIAL

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

ClinicalTrials.gov

This is a clinical trial registry record for an ongoing Phase 1 study with no results posted; the study is actively recruiting and outcome data are not yet available.

PreliminaryEli Lilly and Company LY4257529 Standard of Care Anticancer Therapies

Reported

Estimated enrollment421

Study phasePHASE 1

Primary outcome (Phase 1a dose es…Maximum Tolerated Dose of LY4257496

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support